[[/lab/Pharmacology|Home]] | [[/lab/Pharmacology/res_act|Research]] | [[/lab/Pharmacology/Patents & Awards|Patents & Awards]] | [[/lab/Pharmacology/publications|Publications]]| [[/lab/Pharmacology/staff|Staff]] | [[/lab/Pharmacology/contact|Contact]] | 


{{:staff:apinya:apinya_2013.jpg?300x300|}}    {{:staff:apinya:apinya_2_2013.jpg?300x300|}}

**Name:** 		<color dodgerblue>Apinya Thiantanawat, Ph.D.</color>\\

**Position:**	Senior research scientist\\
<color white>**Position:**  </color>Laboratory of Pharmacology, Chulabhorn Research Institute\\
<color white>**Position:**  </color>Lecturer\\
<color white>**Position:**  </color>Applied Biological Science Program, Chulabhorn Graduate Institute\\

**Education:**

Postdoctoral Training, Department of Biological Engineering, Massachusetts Institute of Technology, Boston, MA, USA\\ 
Ph.D. (Pharmacology), University of Maryland, Baltimore, MD, USA\\
M.Sc. (Pharmacology), Mahidol University, Bangkok, Thailand\\
B.Sc. (Chemical Biology), Silpakorn University, Thailand\\

**Fields of Interest:**\\
1. Biology of cancer emphasized on the role and signal transduction of estrogen and its receptors via either genomic or non-genomic pathways. Current research is focusing on colorectal cancer, breast cancer, hepatocellular carcinoma (HCC), and cholangiocarcinoma (CCA).\\
2. Impact of environmental pollutants and pre-existing diseases that affect estrogen signaling. Study on the effects of heavy metals such as cadmium and arsenic which possess estrogenic and/or antiestrogenic properties on biology of cancer is on progress. \\
3. Drug development for prevention and intervention of cancer. The molecular mechanisms of the potential extracts and pure compounds isolated from Thai medicinal plants are investigated focusing on antioxidant, antiestrogens, apoptosis and cell cycle machinery. \\